Form 4 Filing for Aprea Therapeutics, Inc.

Gruia Gabriela, a director at Aprea Therapeutics, Inc., acquired 3,135 shares of Common Stock on June 16, 2026, with no cost basis, as reported in a Form 4 filing. This transaction brings her total direct ownership to 4,180 shares. Additionally, Gabriela was granted 12,555 stock options, also with no cost basis, vesting on June 16, 2027. The options have an exercise price of $0.7293 and expire on June 16, 2036. These restricted stock units and options are subject to continued service and potential acceleration under certain conditions.